Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma

Carcinogenesis

Volumn 23, Issue 6, 2002, Pages 1017-1024

  Gordon, Gavin J ^a   Appasani, Krishnarao ^a   Parcells, Jeremy P ^a   Mukhopadhyay, Nishit K ^a   Jaklitsch, Michael T ^a   Richards, William G ^a   Sugarbaker, David J ^a   Bueno, Raphael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CASPASE 9; CISPLATIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DRUG SENSITIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MESOTHELIOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; PLEURA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MESOTHELIOMA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PLEURAL NEOPLASMS; PROTEINS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036309455     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.6.1017     Document Type: Article

References (28)

1. Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma
2. Absence of p53 mutations in malignant mesotheliomas
3. p53 and Kirsten-ras mutations in human mesothelioma cell lines
4. Diagnosis, staging and natural history of pleural mesothelioma
5. Therapeutic approaches in malignant mesothelioma
6. Current therapy for mesothelioma
7. Malignant pleural mesothelioma
8. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
9. Patterns of failure after trimodality therapy for malignant pleural mesothelioma
10. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias
11. Inhibitor of apoptosis (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine
12. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
13. IAP family proteins-suppressors of apoptosis
14. Differential display: A general protocol
15. Characterization of a human squamous carcinoma cell line resistant to cis-diammine-dichloroplatinum (II)
16. The alpha folate receptor is highly activated in malignant pleural mesothelioma
17. Vascular endothelial genes that are responsive to tumor necrosis factor-α in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin and two novel genes
18. Genetic factors in the aetiology of malignant mesothelioma
19. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
20. The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance
21. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase 8 activation
22. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis cIAP2 is under NF-κB control
23. Tumor necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer
24. Pathology of mesothelioma
25. Modulation of vindesine and doxorubicin in multi-drug resistant pleural mesothelioma cells by tumor necrosis factor-alpha
26. Malignant mesothelioma: The antiproliferative effect of cytokine combinations on three human mesothelioma cell lines
27. NF-κB activation in response to toxical and therapeutical agents: Role in inflammation and cancer treatment